STRATA Skin Sciences, Inc. (SSKN)
OTCMKTS
· Delayed Price · Currency is USD
0.130
+0.008 (6.56%)
At close: Apr 28, 2026
STRATA Skin Sciences Revenue
In the year 2025, STRATA Skin Sciences had annual revenue of $30.70M, down -8.54%. STRATA Skin Sciences had revenue of $9.29M in the quarter ending December 31, 2025, a decrease of -2.97%.
Revenue
30.70M
Revenue Growth
-8.54%
P/S Ratio
0.02
Revenue / Employee
269.26K
Employees
114
Market Cap
765.47K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.70M | -2.87M | -8.54% |
| Dec 31, 2024 | 33.56M | 204.00K | 0.61% |
| Dec 31, 2023 | 33.36M | -2.80M | -7.75% |
| Dec 31, 2022 | 36.16M | 6.18M | 20.63% |
| Dec 31, 2021 | 29.98M | 6.89M | 29.83% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Electromedical Technologies | 922.01K |
| Escalon Medical | 12.31M |
| Sonendo | 31.70M |
| Fuse Medical | 18.40M |
| Vycor Medical | 1.86M |
| CYduct Diagnostics | 344.78K |
STRATA Skin Sciences News
- 2 months ago - STRATA Skin Sciences Confirms Nasdaq Delisting - GlobeNewsWire
- 2 months ago - Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser - GlobeNewsWire
- 2 months ago - STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis - GlobeNewsWire
- 2 months ago - Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences - GlobeNewsWire
- 5 months ago - STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico - GlobeNewsWire
- 5 months ago - STRATA Skin Sciences Earnings Call Transcript: Q3 2025 - Transcripts
- 6 months ago - STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion - GlobeNewsWire
- 6 months ago - STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update - GlobeNewsWire